You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Merck
Baxter
AstraZeneca
McKesson

Last Updated: April 6, 2020

DrugPatentWatch Database Preview

Drug Price Trends for TIAGABINE HCL


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Drug Price Trends for TIAGABINE HCL

Average Pharmacy Cost for TIAGABINE HCL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
TIAGABINE HCL 4 MG TABLET 00093-5031-56 4.44050 EACH 2020-03-18
TIAGABINE HCL 4 MG TABLET 62756-0224-83 4.44050 EACH 2020-03-18
TIAGABINE HCL 4 MG TABLET 69238-1105-03 4.44050 EACH 2020-03-18
TIAGABINE HCL 4 MG TABLET 62756-0224-83 5.28637 EACH 2020-02-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for TIAGABINE HCL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
GABITRIL 16MG TAB Teva Pharmaceuticals USA, Inc. 63459-0416-30 30 247.69 8.25633 EACH 2019-01-01 - 2022-08-14 Big4
GABITRIL 12MG TAB Teva Pharmaceuticals USA, Inc. 00093-8072-56 30 179.39 5.97967 EACH 2020-01-01 - 2022-08-14 FSS
GABITRIL 16MG TAB Teva Pharmaceuticals USA, Inc. 00093-8076-56 30 203.01 6.76700 EACH 2020-01-01 - 2022-08-14 FSS
GABITRIL 4MG Teva Pharmaceuticals USA, Inc. 63459-0404-30 30 194.86 6.49533 EACH 2020-01-01 - 2022-08-14 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.